U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C31H32Cl2N4O4S
Molecular Weight 627.581
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LPT-99

SMILES

COC1=CC2=C(NC=C2CCNC(=O)CC3N(CCC4=CC=CS4)C(=O)CN(CCC5=CC=C(Cl)C=C5Cl)C3=O)C=C1

InChI

InChIKey=XLXXBYJYWULGGD-UHFFFAOYSA-N
InChI=1S/C31H32Cl2N4O4S/c1-41-23-6-7-27-25(16-23)21(18-35-27)8-11-34-29(38)17-28-31(40)36(12-9-20-4-5-22(32)15-26(20)33)19-30(39)37(28)13-10-24-3-2-14-42-24/h2-7,14-16,18,28,35H,8-13,17,19H2,1H3,(H,34,38)

HIDE SMILES / InChI

Molecular Formula C31H32Cl2N4O4S
Molecular Weight 627.581
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 13:45:34 GMT 2023
Edited
by admin
on Sat Dec 16 13:45:34 GMT 2023
Record UNII
A2Y8E9P363
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LPT-99
Code English
2-(4-(2,4-DICHLOROPHENETHYL)-3,6-DIOXO-1-(2-(THIOPHEN-2-YL)ETHYL)PIPERAZIN-2-YL)-N-(2-(5-METHOXY-1H-INDOL-3-YL)ETHYL)ACETAMIDE
Common Name English
2-PIPERAZINEACETAMIDE, 4-(2-(2,4-DICHLOROPHENYL)ETHYL)-N-(2-(5-METHOXY-1H-INDOL-3-YL)ETHYL)-3,6-DIOXO-1-(2-(2-THIENYL)ETHYL)-
Common Name English
LPT99
Code English
2-(4-(2,4-DICHLOROPHENETHYL)-3,6-DIOXO-1-(2-(THIOPHEN-2-YL)ETHYL)PIPERAZIN-2-YL)-N-(2-(5-METHOXY-1H-INDOL-3-YL)ETHYL) ACETAMIDE
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 618517
Created by admin on Sat Dec 16 13:45:34 GMT 2023 , Edited by admin on Sat Dec 16 13:45:34 GMT 2023
Code System Code Type Description
FDA UNII
A2Y8E9P363
Created by admin on Sat Dec 16 13:45:34 GMT 2023 , Edited by admin on Sat Dec 16 13:45:34 GMT 2023
PRIMARY
PUBCHEM
69619483
Created by admin on Sat Dec 16 13:45:34 GMT 2023 , Edited by admin on Sat Dec 16 13:45:34 GMT 2023
PRIMARY
CAS
1263477-83-3
Created by admin on Sat Dec 16 13:45:34 GMT 2023 , Edited by admin on Sat Dec 16 13:45:34 GMT 2023
PRIMARY